Document is current
Any future updates will be listed below
-
Authors
Cheng, Li https://orcid.org/0009-0001-7602-4979
Zhao, Shijun
Li, Tianyi
Hou, Sha
Luo, Zhouqing
Xu, Jinsheng
Yu, Wenfei https://orcid.org/0000-0002-1196-6236
Jiang, Shuangying https://orcid.org/0000-0002-6786-6533
Monti, Marco https://orcid.org/0000-0003-1266-4325
Schindler, Daniel
Zhang, Weimin https://orcid.org/0000-0002-8836-1438
Hou, Chunhui https://orcid.org/0000-0002-8339-1857
Ma, Yingxin
Cai, Yizhi https://orcid.org/0000-0003-1663-2865
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Dai, Junbiao https://orcid.org/0000-0002-5299-4700
- License Information
-
More Information
Article History
Received: 30 June 2023
Accepted: 13 December 2023
First Online: 26 January 2024
Competing interests
: J.D.B. is a Founder and Director of CDI Labs, Inc., a Founder of and consultant to Neochromosome, Inc, a Founder, SAB member of and consultant to ReOpen Diagnostics, LLC and serves or served on the Scientific Advisory Board of the following: Logomix, Inc., Modern Meadow, Inc., Rome Therapeutics, Inc., Sample6, Inc., Sangamo, Inc., Tessera Therapeutics, Inc., and the Wyss Institute. The remaining authors declare no competing interests.
